Deterioration of the immune system due to antibiotic therapy can be restored by immunomodulator application. In this paper we estimate the effect of ampicillin, amikacin, doxycycline, rifampicin, ...

The company is owned by the Chibret family, who have played a major role in the history of ophthalmology and pharmaceuticals in France, with a legacy spanning 150 Years. Their influence began in the ...

The independent and family-owned and run group, founded from a R&D start-up by Henri Chibret, has been chaired since 2008 by Jean-Frédéric Chibret, his nephew.

Théa Pharma has strong French roots, with 150 years of heritage in eye care through the Chibret family. This year Théa celebrates 30 years and is proudly based in Castlebar and has become Ireland’s ...

HEIDELBERG, Germany & CAMBRIDGE, Mass. & CLERMONT-FERRAND, France, October 02, 2024--Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the ...

Global Data. Dry Eye Syndrome: Seven-Market Drug Forecast and Market Analysis Update | December 2022 Jones et al. TFOS DEWSII Management and Therapy Report. The Ocular Surface. 2017; 15 (3): 575-628 ...

Kiora Pharmaceuticals Inc announced it has entered a strategic development and commercialization agreement with Théa Open Innovation (TOI), a sister company of the global ophthalmic specialty company ...

Article citations More>> Bennsman, A. Infection de l’appareil urinaire chez l’enfant. Meyrier Alain des infections de l’appareil urinaire préface du Pr. François Vachon. Editions médicales de Merck ...

PARIS-- (BUSINESS WIRE)-- Tilak Healthcare, a pioneer and leading player in the field of ophthalmological digital health, has raised €10 million in a funding round led by Elaia and Cap Horn. They were ...

Agreement provides ProQR with initial payment of €12.5M and up to €135M in further payments, as well as potential additional earn outs based on commercial sales in the US and EU Divestment of ...

The independent and family-owned and run group, founded from a Research and Development start-up by Henri Chibret, has been chaired since 2008 by Jean-Frédéric Chibret, his nephew.